The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis
Open accessAbstract
Objective: To evaluate the incidence and prevalence of autoimmune encephalitis and compare it to that of infectious encephalitis. Methods: We performed a population‐based comparative study of the incidence and prevalence of autoimmune and infectious encephalitis in Olmsted County, Minnesota. Autoimmune encephalitis diagnosis and subgroups were defined by 2016 diagnostic criteria, and infectious encephalitis diagnosis required a confirmed infectious pathogen. Age‐ and sex‐adjusted prevalence and incidence rates were calculated. Patients with encephalitis of uncertain etiology were excluded. Results: The prevalence of autoimmune encephalitis on January 1, 2014 of 13.7/100,000 was not significantly different from that of all infectious encephalitides (11.6/100,000; p = 0.63) or the viral subcategory (8.3/100,000; p = 0.17). The incidence rates (1995–2015) of autoimmune and infectious encephalitis were 0.8/100,000 and 1.0/100,000 person‐years, respectively ( p = 0.58). The number of relapses or recurrent hospitalizations was higher for autoimmune than infectious encephalitis ( p = 0.03). The incidence of autoimmune encephalitis increased over time from 0.4/100,000 person‐years (1995–2005) to 1.2/100,000 person‐years (2006–2015; p = 0.02), attributable to increased detection of autoantibody‐positive cases. The incidence (2.8 vs 0.7/100,000 person‐years, p = 0.01) and prevalence (38.3 vs 13.7/100,000, p = 0.04) of autoimmune encephalitis was higher among African Americans than Caucasians. The prevalence of specific neural autoantibodies was as follows: myelin oligodendrocyte glycoprotein, 1.9/100,000; glutamic acid decarboxylase 65, 1.9/100,000; unclassified neural autoantibody, 1.4/100,000; leucine‐rich glioma‐inactivated protein 1, 0.7/100,000; collapsin response‐mediator protein 5, 0.7/100,000; N‐methyl‐D‐aspartate receptor, 0.6/100,000; antineuronal nuclear antibody type 2, 0.6/100,000; and glial fibrillary acidic protein α, 0.6/100,000. Interpretation: This study shows that the prevalence and incidence of autoimmune encephalitis are comparable to infectious encephalitis, and its detection is increasing over time. Ann Neurol 2018;83:166–177
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A clinical approach to diagnosis of autoimmune encephalitis
Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., Cortese, I., Dale, R. C., Gelfand, J. M., Geschwind, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00401-9 · Cited by 4,516
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
Dalmau, J., Gleichman, A. J., Hughes, E. G., Rossi, J. E., Peng, X., Lai, M., Dessain, S. K., Rosenfeld, M. R., Balice-Gordon, R., & Lynch, D. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70224-2 · Cited by 3,488
Titulaer, M. J., McCracken, L., Gabilondo, I., Armangué, T., Glaser, C., Iizuka, T., Honig, L. S., Benseler, S. M., Kawachi, I., Martinez-Hernandez, E., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70310-1 · Cited by 3,165
Granerod, J., Ambrose, H. E., Davies, N. W., Clewley, J. P., Walsh, A. L., Morgan, D., Cunningham, R., Zuckerman, M., Mutton, K. J., Solomon, T., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70222-x · Cited by 1,358
Venkatesan, A., Tunkel, A. R., Bloch, K. C., Lauring, A. S., Sejvar, J., Bitnun, A., Stahl, J.-P., Mailles, A., Drebot, M., Rupprecht, C. E., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit458 · Cited by 1,197
Actionable Diagnosis of Neuroleptospirosis by Next-Generation Sequencing
Wilson, M. R., Naccache, S. N., Samayoa, E., Biagtan, M., Bashir, H., Yu, G., Salamat, S. M., Somasekar, S., Federman, S., Miller, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401268 · Cited by 977
Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis
Irani, S. R., Michell, A. W., Lang, B., Pettingill, P., Waters, P., Johnson, M. R., Schott, J. M., Armstrong, R. J. E., S. Zagami, A., Bleasel, A., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22307 · Cited by 928
Rocca, W. A., Yawn, B. P., St. Sauver, J. L., Grossardt, B. R., & Melton, L. J. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.08.012 · Cited by 791
Clinical presentation and prognosis in MOG-antibody disease: a UK study
Jurynczyk, M., Messina, S., Woodhall, M. R., Raza, N., Everett, R., Roca-Fernandez, A., Tackley, G., Hamid, S., Sheard, A., Reynolds, G., et al. (2017) · Brain · doi:10.1093/brain/awx276 · Cited by 740
Gable, M. S., Sheriff, H., Dalmau, J., Tilley, D. H., & Glaser, C. A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir1038 · Cited by 733
Data Resource Profile: The Rochester Epidemiology Project (REP) medical records-linkage system
St Sauver, J. L., Grossardt, B. R., Yawn, B. P., Melton, L. J., Pankratz, J. J., Brue, S. M., & Rocca, W. A. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dys195 · Cited by 613
Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Novel Meningoencephalomyelitis
Fang, B., McKeon, A., Hinson, S. R., Kryzer, T. J., Pittock, S. J., Aksamit, A. J., & Lennon, V. A. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.2549 · Cited by 568
Self-citationFlanagan, E. P., Hinson, S. R., Lennon, V. A., Fang, B., Aksamit, A. J., Morris, P. P., Basal, E., Honorat, J. A., Alfugham, N. B., Linnoila, J. J., et al. (2017) · Annals of Neurology · doi:10.1002/ana.24881 · Cited by 550
Self-citationIrani, S. R., Stagg, C. J., Schott, J. M., Rosenthal, C. R., Schneider, S. A., Pettingill, P., Pettingill, R., Waters, P., Thomas, A., Voets, N. L., et al. (2013) · Brain · doi:10.1093/brain/awt212 · Cited by 437
Glaser, C. A., Gilliam, S., Schnurr, D., Forghani, B., Honarmand, S., Khetsuriani, N., Fischer, M., Cossen, C. K., & Anderson, L. J. (2003) · Clinical Infectious Diseases · doi:10.1086/367841 · Cited by 434
Expanded phenotypes and outcomes among 256 LGI 1/ CASPR 2‐ I g G –positive patients
Gadoth, A., Pittock, S. J., Dubey, D., McKeon, A. B., Britton, J. W., Schmeling, J. E., Smith, A., Kotsenas, A. L., Watson, R. E., Lachance, D. H., et al. (2017) · Annals of Neurology · doi:10.1002/ana.24979 · Cited by 398
Self-citationBurden of encephalitis-associated hospitalizations in the United States, 1998-2010
Vora, N. M., Holman, R. C., Mehal, J. M., Steiner, C. A., Blanton, J., & Sejvar, J. (2014) · Neurology · doi:10.1212/wnl.0000000000000086 · Cited by 264
Encephalitis hospitalization rates and inpatient mortality in the United States, 2000-2010
George, B. P., Schneider, E. B., & Venkatesan, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104169 · Cited by 263
Glutamic Acid Decarboxylase Autoimmunity With Brainstem, Extrapyramidal, and Spinal Cord Dysfunction
Pittock, S. J., Yoshikawa, H., Ahlskog, J. E., Tisch, S. H., Benarroch, E. E., Kryzer, T. J., & Lennon, V. A. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.9.1207 · Cited by 231
Self-citationHerpes simplex virus–1 encephalitis can trigger anti-NMDA receptor encephalitis: Case report
Leypoldt, F., Titulaer, M. J., Aguilar, E., Walther, J., Bönstrup, M., Havemeister, S., Teegen, B., Lütgehetmann, M., Rosenkranz, M., Magnus, T., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a9f531 · Cited by 187
Next-generation sequencing in neuropathologic diagnosis of infections of the nervous system
(2016) · doi:10.1212/nxi.0000000000000251 · Cited by 171
The epidemiology of acute encephalitis
Granerod, J., & Crowcroft, N. S. (2007) · Neuropsychological Rehabilitation · doi:10.1080/09602010600989620 · Cited by 168
Paraneoplastic encephalomyelopathies: pathology and mechanisms
McKeon, A., & Pittock, S. J. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0876-1 · Cited by 164
Self-citationWalikonis, J., & Lennon, V. A. (1998) · Mayo Clinic Proceedings · doi:10.4065/73.12.1161 · Cited by 164
Self-citationRacial Disparities in Medical Care
Epstein, A. M., & Ayanian, J. Z. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441911 · Cited by 161
CSF herpes virus and autoantibody profiles in the evaluation of encephalitis
Linnoila, J., Binnicker, M. J., Majed, M., Klein, C. J., & McKeon, A. B. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000245 · Cited by 129
Self-citationEncephalitis and aseptic meningitis, Olmsted County, Minnesota, 1950–1981: I. Epidemiology
Beghi, E., Nicolosi, A., Kurland, L. T., Mulder, D. W., Hauser, W. A., & Shuster, L. T. (1984) · Annals of Neurology · doi:10.1002/ana.410160304 · Cited by 124
Diagnosis and management of acute encephalitis: A practical approach
Venkatesan, A., & Geocadin, R. G. (2014) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000036 · Cited by 122
Improving the antibody-based evaluation of autoimmune encephalitis
McCracken, L., Zhang, J., Greene, M. I., Crivaro, A., González, J., Kamoun, M., & Lancaster, E. (2017) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000404 · Cited by 98
Frequencies of neuronal autoantibodies in healthy controls: Estimation of disease specificity
Lang, K., & Prüß, H. (2017) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000386 · Cited by 82
Encephalitis, Ontario, Canada, 2002–2013
Parpia, A. S., Li, Y., Chen, C., Dhar, B., & Crowcroft, N. S. (2016) · Emerging infectious diseases · doi:10.3201/eid2203.151545 · Cited by 36
Cited by
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
Graus, F., Vogrig, A., Muñiz-Castrillo, S., Antoine, J.-C. G., Desestret, V., Dubey, D., Giometto, B., Irani, S. R., Joubert, B., Leypoldt, F., et al. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001014 · Cited by 759
Self-citationAutoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management
Abboud, H., Probasco, J. C., Irani, S., Ances, B., Benavides, D. R., Bradshaw, M., Christo, P. P., Dale, R. C., Fernandez-Fournier, M., Flanagan, E. P., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-325300 · Cited by 554
Self-citationLópez-Chiriboga, A. S., Majed, M., Fryer, J., Dubey, D., McKeon, A., Flanagan, E. P., Jitprapaikulsan, J., Kothapalli, N., Tillema, J.-M., Chen, J., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.1814 · Cited by 410
Self-citationB cells in autoimmune and neurodegenerative central nervous system diseases
Sabatino, J. J., Pröbstel, A.-K., & Zamvil, S. S. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0233-2 · Cited by 343
Autoantibodies in neurological disease
Prüss, H. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00543-w · Cited by 319
Metadata
- Authors
- Dubey, D., Pittock, S. J., Kelly, C. R., McKeon, A., Lopez‐Chiriboga, A. S., Lennon, V. A., Gadoth, A., Smith, C. Y., Bryant, S. C., Klein, C. J., Aksamit, A. J., Toledano, M., Boeve, B. F., Tillema, J.-M., & Flanagan, E. P.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2018-01
- Volume
- 83
- Issue
- 1
- Pages
- 166-177
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2782339488
- Cited by
- 777
- References
- 31
- FWCI
- 39.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.